ITI-214 free base 是一种有效的中枢神经系统活性抑制剂，具有口服生物活性的 PDE1 抑制剂 (Ki of 58 pM)，对其他PDE家族成员和一系列酶、受体、转运体和离子通道具有良好的选择性。ITI-214 free base 分别以 33 pM、380 pM和 35 pM 的 Ki 抑制重组人 PDE1A、PDE1B 和 PDE1C。ITI-214 free base 在各种运动和认知功能的动物模型中显示出有效性。
| 生物活性 |
ITI-214 free base is a potent, CNS-active, orally bioavailable PDE1 inhibitor (Ki of 58 pM) with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters and ion channels. ITI-214 free base inhibits recombinant full-length human PDE1A, PDE1B and PDE1C with Kis of 33 pM, 380 pM and 35 pM, respectively. ITI-214 free base shows efficacy in various animal models of motor and cognitive functions. |
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 体外研究 |
ITI-214 is found to potently inhibit the activity of full-length recombinant r-hPDE1A (Ki= 34 pM), r-hPDE1B (Ki= 380 pM), and r-hPDE1C (Ki= 37 pM) enzymes transiently expressed in HEK cells. The compound expressed >1000-fold greater activity toward PDE1 isoforms compared with the next nearest PDE family enzyme, PDE4D (Ki= 33 nM) and 10,000-300,000-fold selectivity toward all other PDE enzyme families. |
||||||||||||
| 体内研究 |
ITI-214 significantly enhances memory performance in the test with a minimum effective dose of 3 mg/kg.
|
||||||||||||
| 分子式 |
C29H26FN7O
|
||||||||||||
| 分子量 |
507.56
|
||||||||||||
| CAS号 |
1160521-50-5
|
||||||||||||
| 运输条件 |
Room temperature in continental US; may vary elsewhere. |
||||||||||||
| 储存方式 |
|
||||||||||||
| 临床试验 |
|
纯度： ≥98%
关注我们
获得KKL MED 最新资讯
客服小K 
客服小K
Data Sheet